102 related articles for article (PubMed ID: 1568173)
1. DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinicomorphologic study of 80 cases.
Padberg BC; Arps H; Franke U; Thiedemann C; Rehpenning W; Stegner HE; Lietz H; Schröder S; Dietel M
Cancer; 1992 May; 69(10):2510-4. PubMed ID: 1568173
[TBL] [Abstract][Full Text] [Related]
2. DNA cytophotometry and prognosis in typical and atypical bronchopulmonary carcinoids. A clinicomorphologic study of 100 neuroendocrine lung tumors.
Padberg BC; Woenckhaus J; Hilger G; Beccu L; Jochum W; Range U; Kastendieck H; Schröder S
Am J Surg Pathol; 1996 Jul; 20(7):815-22. PubMed ID: 8669529
[TBL] [Abstract][Full Text] [Related]
3. DNA-cytophotometry and immunocytochemistry in ovarian tumours of borderline malignancy and related peritoneal lesions.
Padberg BC; Stegner HE; von Sengbusch S; Arps H; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):497-503. PubMed ID: 1466153
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry.
Jochum W; Schröder S; al-Taha R; August C; Gross AJ; Berger J; Padberg BC
Cancer; 1996 Feb; 77(3):514-21. PubMed ID: 8630959
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
7. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
Friedlander ML; Hedley DW; Swanson C; Russell P
J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
Borgmann V; al-Abadi H; Nagel R
Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
[TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA analysis: DNA heterogeneity in the monitoring of patients with locally advanced prostatic carcinoma.
al-Abadi H; Nagel R
Eur Urol; 1992; 22(4):303-10. PubMed ID: 1490508
[TBL] [Abstract][Full Text] [Related]
10. Ploidy disturbances in endometrial and ovarian carcinomas. A review.
Iversen OE; Laerum OD
Anal Quant Cytol Histol; 1985 Dec; 7(4):327-36. PubMed ID: 3911973
[TBL] [Abstract][Full Text] [Related]
11. DNA cytophotometry in malignant thyroid tumors--use of different evaluation schemes for prognostic statements.
Arps H; Sablotny B; Dietel M; Niendorf A; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1988; 413(4):319-23. PubMed ID: 3140476
[TBL] [Abstract][Full Text] [Related]
12. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
13. DNA cytophotometric findings in pheochromocytoma.
Padberg BC; Garbe E; Achilles E; Dralle H; Bressel M; Schroder S
Henry Ford Hosp Med J; 1989; 37(3-4):185-6. PubMed ID: 2576960
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of the DNA distribution in squamous-cell carcinomas of the uterine cervix.
Göppinger A; Freudenberg N; Ross A; Hillemans HG; Hilgarth M
Anal Quant Cytol Histol; 1986 Jun; 8(2):148-51. PubMed ID: 3730088
[TBL] [Abstract][Full Text] [Related]
15. [Cervix uteri cancer: determination of DNA content by means of cytophotometry].
Wistuba I; Roa I; Villaseca MA; Araya JC; Capurro I
Rev Med Chil; 1993 Aug; 121(8):873-9. PubMed ID: 8296094
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary.
Klemi PJ; Joensuu H; Salmi T
Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667
[TBL] [Abstract][Full Text] [Related]
17. [Morphologic criteria of prognosis and clinical course in ovarian tumors of the borderline type].
Kühn W; Hanke J; Feichter GE; Rummel HH; Schmid H; Schmidt W; Kaufmann M
Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):173-8. PubMed ID: 3582924
[TBL] [Abstract][Full Text] [Related]
18. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of nuclear DNA of 106 colorectal tumors, determined with microspectrocytophotometry].
Díaz Aguirregoitia FJ; García-Alonso Montoya I; Iturburu Belmonte I; Portugal Porras V; Alonso Varona A; Echevarría García-Sanfrechoso A; Méndez Martín J
Rev Esp Enferm Dig; 1993 Jun; 83(6):421-8. PubMed ID: 8338705
[TBL] [Abstract][Full Text] [Related]
20. The role of DNA flow cytometry in borderline malignant ovarian tumors.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
